Arkolith/Insider Trading/RCUS/Form 4

Azoy Alexander

Chief Accounting OfficerArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Dec 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$49K
Net Open-Market Flow
-$49K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2025Sell(S)2K$26.00$49K27K
Nov 26, 2025Option exercise(M)2K$13.33$25K29K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 26, 2025Option exercise(M)2K—$010K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001771961-25-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML